HK1147210A1 - Anti-hypertensive agent - Google Patents

Anti-hypertensive agent

Info

Publication number
HK1147210A1
HK1147210A1 HK11101428.7A HK11101428A HK1147210A1 HK 1147210 A1 HK1147210 A1 HK 1147210A1 HK 11101428 A HK11101428 A HK 11101428A HK 1147210 A1 HK1147210 A1 HK 1147210A1
Authority
HK
Hong Kong
Prior art keywords
seq
trp
lys
val
gly
Prior art date
Application number
HK11101428.7A
Other languages
English (en)
Inventor
Kyoichi Kagawa
Chizuko Fukuhama
Hiroaki Fujino
Junnei Hidasa
Original Assignee
Mg Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mg Pharma Inc filed Critical Mg Pharma Inc
Publication of HK1147210A1 publication Critical patent/HK1147210A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK11101428.7A 2007-08-07 2011-02-15 Anti-hypertensive agent HK1147210A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007204929 2007-08-07
PCT/JP2008/064247 WO2009020189A1 (ja) 2007-08-07 2008-08-07 血圧降下剤

Publications (1)

Publication Number Publication Date
HK1147210A1 true HK1147210A1 (en) 2011-08-05

Family

ID=40341418

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11101428.7A HK1147210A1 (en) 2007-08-07 2011-02-15 Anti-hypertensive agent
HK14100238.6A HK1187256A1 (en) 2007-08-07 2014-01-09 Anti-hypertensive agent

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK14100238.6A HK1187256A1 (en) 2007-08-07 2014-01-09 Anti-hypertensive agent

Country Status (9)

Country Link
US (1) US8394769B2 (ja)
EP (1) EP2179740B1 (ja)
JP (4) JPWO2009020189A1 (ja)
KR (1) KR101244331B1 (ja)
CN (2) CN103251928B (ja)
AU (1) AU2008284709C1 (ja)
CA (1) CA2695666C (ja)
HK (2) HK1147210A1 (ja)
WO (1) WO2009020189A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018001273A1 (zh) * 2016-06-30 2018-01-04 江西本草天工科技有限责任公司 肽或其盐、其制备方法、及其制备预防和/或治疗肝损伤药物的用途
CN107551258B (zh) * 2016-06-30 2021-01-05 江西本草天工科技有限责任公司 用于预防和/或治疗肝损伤的vvyp
CN108618101B (zh) * 2018-05-10 2021-11-23 华南理工大学 一种具有鲜味和增鲜作用的三肽及其衍生物和用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1335567C (en) 1988-02-02 1995-05-16 Kyoichi Kagawa Lipid metabolism promoting agent
JPH07188282A (ja) * 1991-04-19 1995-07-25 Suetsuna Yoko 新規なトリペプチド、その製法およびそれを有効成分と する血圧降下剤
JP2805194B2 (ja) * 1996-03-22 1998-09-30 阪急共栄物産株式会社 血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤
JP3108675B2 (ja) * 1998-03-17 2000-11-13 阪急共栄物産株式会社 脂質代謝改善剤
WO2001068674A2 (en) * 2000-03-13 2001-09-20 Monsanto Technology Llc Preparation of recombinant proteins containing repeating units
JP3716298B2 (ja) 2000-09-04 2005-11-16 国立大学法人京都大学 新規な降圧ペプチド
DE10133576A1 (de) * 2001-07-13 2003-01-30 Martin Klingmueller Verwendung von physiologisch aktiven Oligopeptiden zur Stabilisierung des Immunsystems
EP2048159B1 (en) * 2002-11-09 2014-01-01 Immunocore Ltd. T cell receptor display
JP2004175680A (ja) * 2002-11-25 2004-06-24 Marine Bio Kk 生体バランス改善効果を備えたミネラル含有組成物
JP2005046083A (ja) * 2003-07-30 2005-02-24 Morinaga & Co Ltd グロビン蛋白分解物含有飲料及びその製造方法
JP4769193B2 (ja) * 2004-09-30 2011-09-07 サントリーホールディングス株式会社 グロビン蛋白分解物を含有する酵母発酵飲料
EP1824501B1 (en) * 2004-11-15 2009-08-19 Mg Pharma Inc. Protein hydrolysate with antidiabetic effect
JP2006180840A (ja) * 2004-12-28 2006-07-13 Hiroshima Pref Gov 血栓の溶解を亢進させるポリペプチド及びその利用
JP4395658B2 (ja) * 2005-11-17 2010-01-13 エムジーファーマ株式会社 コレステロール再上昇抑制用組成物およびその用法
CN1990875A (zh) * 2005-12-30 2007-07-04 中国科学院大连化学物理研究所 一种珠蛋白酶解物及其制备和应用
CN1994464B (zh) * 2005-12-31 2010-05-05 中国科学院大连化学物理研究所 一种血管紧张素i转换酶抑制剂及其应用
JP5041780B2 (ja) * 2006-10-23 2012-10-03 エムジーファーマ株式会社 肝障害改善組成物

Also Published As

Publication number Publication date
JPWO2009020189A1 (ja) 2010-11-04
JP5850870B2 (ja) 2016-02-03
HK1187256A1 (en) 2014-04-04
WO2009020189A1 (ja) 2009-02-12
CN101815525A (zh) 2010-08-25
JP2013116911A (ja) 2013-06-13
JP2013144696A (ja) 2013-07-25
CA2695666A1 (en) 2009-02-12
KR101244331B1 (ko) 2013-03-18
JP5850869B2 (ja) 2016-02-03
US8394769B2 (en) 2013-03-12
KR20100051838A (ko) 2010-05-18
EP2179740A1 (en) 2010-04-28
JP5985028B2 (ja) 2016-09-06
AU2008284709A1 (en) 2009-02-12
EP2179740A4 (en) 2010-09-29
US20110166073A1 (en) 2011-07-07
AU2008284709C1 (en) 2014-06-05
EP2179740B1 (en) 2014-10-08
CN101815525B (zh) 2013-05-29
CN103251928B (zh) 2014-11-26
CN103251928A (zh) 2013-08-21
CA2695666C (en) 2016-05-17
JP2016026194A (ja) 2016-02-12

Similar Documents

Publication Publication Date Title
EP1801206A4 (en) PROCESS FOR THE PREPARATION OF L-ARGININE, L-ORNITHIN OR L-CITRULLINE
IN2014CN02050A (ja)
PT1927597T (pt) Péptidos antibacterianos
DK2162462T3 (da) Cxc-chemokin-receptor-4 (cxcr4) antagonistisk polypeptid
HK1134507A1 (en) Peptide vaccines for cancers expressing tumor-associated antigens
WO2007056362A3 (en) Glucagon analogs exhibiting physiological solubility and stability
WO2007076162A3 (en) Antimicrobial cathelicidin peptides
NZ602351A (en) Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use
EA201170878A1 (ru) Полипептиды с ксиланазной активностью
MX2011011960A (es) Peptidos penetradores de celulas.
CR9570A (es) Formulaciones y usos del peptido receptor de eritropoyetina
NZ604818A (en) Variants of activin iib receptor polypeptides and uses thereof
WO2007097903A3 (en) Hiv fusion inhibitor peptides with improved biological properties
WO2009025116A1 (ja) Cdh3ペプチド及びこれを含む薬剤
WO2008113536A8 (en) Neurotrophic peptides
WO2005074626A3 (en) Compositions, methods and uses for a novel family of peptides
WO2007029262A3 (en) Compositions and methods using same for the detection of viruses
WO2010057242A3 (de) Vakzin
EP1842911A4 (en) HLA BINDING PEPTIDES, FOR THOSE CODING DNA FRAGMENTS AND RECOMBINANT VECTORS
WO2006103101A3 (en) MEANS FOR THE INHIBITION OF ANTI-β1-ADRENERGIC RECEPTOR ANTIBODIES
HK1147210A1 (en) Anti-hypertensive agent
WO2006090090A3 (fr) Epitopes de vih et composition pharmaceutique les contenant
WO2005072766A3 (en) Peptides that bind to hsp90 proteins
EP1757687A4 (en) HLA BINDING PEPTIDE, PRE-STEP, DNA DOMAGING AND RECOMBINANT VECTOR
ATE551353T1 (de) Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten